Coveham House
Downside Bridge Road
Cobham KT11 3EP
United Kingdom
44 20 7043 2116
https://www.proteomics.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 35
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Mariola Sohngen | CEO & Executive Director | 304.44k | N/A | 1961 |
Mr. Abdelghani Omari | CFO & Director | 247.29k | N/A | 1976 |
Dr. Ian H. Pike | Chief Scientific Officer & Executive Director | 285.78k | N/A | 1964 |
Mr. Richard Paul Dennis | Chief Commercial Officer & Executive Director | 241.46k | N/A | 1958 |
Victoria Joanna Birse | Company Secretary | N/A | N/A | N/A |
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.
Proteome Sciences plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.